Viral vector designed to treat a genetic form of blindness

Researchers have developed a viral vector designed to deliver a gene into the eyes of people born with an inherited, progressive form of blindness that affects mainly males. The vector is being tested in a clinical trial investigating the use of gene therapy to cure choroideremia, a disease that affects an estimated 100,000 people worldwide.

Read the whole article on Science Daily

More from Science Daily